Absci Corporation recently announced positive interim Phase 1 clinical trial data for its innovative antibody drug ABS-201.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This medication is designed to target prolactin receptors, with relevant data coming from its study named "Headline™".
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
XRP Breakout Incoming As Long As This Support Zone Holds
TimesTabloid•2026/09/14 16:03
UBS raises PVA TePla stake to 5.05% from 4.97% via instruments`
Reuters•2026/09/14 15:58
MOBA Network names co-founder Björn Mannerqvist CEO, replacing Anders Ribbing
Reuters•2026/09/14 15:58
Crypto prices
MoreBitcoin
BTC
$78,578.57
+1.88%
Ethereum
ETH
$2,508.48
+0.75%
Tether USDt
USDT
$0.9997
-0.00%
BNB
BNB
$721.96
+0.46%
XRP
XRP
$1.4
+4.49%
USDC
USDC
$0.9999
-0.00%
Solana
SOL
$102.14
+1.82%
TRON
TRX
$0.3401
-0.31%
Hyperliquid
HYPE
$80.01
+2.41%
Zcash
ZEC
$1,138.17
+4.55%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now